+100%-
future long COVID

The future got a little brighter for people with long COVID.

It’s wild times, indeed. Sometimes it seems like the earth is shifting beneath our feet. Other times it feels like it’s standing still.

It’s good times for long COVID, though, as the future just got a bit brighter. As many people with long COVID continue to get the cold shoulder from their doctors, the Biden Administration, it appears, has their back.

President Biden issued a Presidential Memorandum directing the Secretary of Health and Human Services (HHS) to create a long-COVID command center that has all the federal health agencies (NIH, FDA, CDC, AHRQ, etc.) together to produce a national research action plan on long COVID and…associated conditions.

A “memorandum” (“a written message in business or diplomacy”, “a note or record made for future use”) may not sound like a big deal, but a “Presidential Memorandum”  carries some real weight. It “has the force of law and is usually used to delegate tasks, direct specific government agencies to do something, or to start a regulatory process”.

So this Presidential Memorandum is going to make things happen. The first thing it’s going to make happen is the creation of the action plan. That, again, may not sound too exciting, but action plans provide the basis for, well, action. They’re what the federal government uses to move forward.

Diana Berrent, founder of Survivor Corps told the Associated Press, “This is the first effort that truly comports with the needs of people who are suffering”. She sees this effort “as a global, comprehensive approach to an extremely thorny issue that has previously received a scattershot approach.”

As our experience with ME/CFS has shown over the years, doctors are often the most resistant to new information and the last to get it about diseases like ME/CFS and long COVID. That will surely change as the Feds will quickly disseminate best care practices as they arise. Help with Medicare, disability, and insurance coverage is included as well.

Like This Blog?

Make Sure You Don't Miss Another One!

Register for our free ME/CFS, fibromyalgia, and long COVID blogs here.

Dr. Leana Wen, a former Baltimore health commissioner highlighted the work on treatments and disability:

“This is a very important move on the part of the Biden administration to acknowledge that long COVID is real, that it is a significant threat, and that much more needs to be done. The emphasis on treatment for long COVID, and recognizing that this could be a source of ongoing disability, are long overdue.”

There’s not a ton of money attached to this ($20 million initially) and much more is needed (Centers of Excellence for one), but it’s a good start. The report will increase long COVID’s visibility, give it a nice platform within the federal government for future efforts, and the overall effort will support people with long COVID in several ways.

Because the memorandum specifically mentions ME/CFS, dysautonomia, and MCAS in connection with long COVID, the opportunity exists – and our advocates will surely push for this – for the big strategic report at the end of the year to lay out the next steps that include other post-infectious diseases like ME/CFS in its recommendations. The NIH and other agencies would find it hard, indeed, to resist those directives.

Solve M.E. President Oved Amitay highlighted that opportunity when he stated:

“It is critically important that the Presidential Memorandum acknowledges the need to learn from other post-infection diseases such as myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), dysautonomia, and mast cell activation syndrome (MCAS) that are strikingly similar to Long Covid. We believe that this field-wide approach will improve outcomes for the millions of people who are affected by all of these diseases.”

One thing we’ve learned – federally funded/produced reports can actually make a difference. It was the federally funded 2015 “Beyond myalgic encephalomyelitis/chronic fatigue syndrome: an IOM report on redefining an illness” that paved the way for the 3 NIH-funded ME/CFS research centers and Nath’s Intramural ME/CFS study. Seven years later, one would have thought that a pandemic of ME/CFS-like long-COVID cases would have done even more, but our support at the NIH has actually waned in some ways. These reports matter and it’s good to see a memorandum that takes these diseases seriously.

If only the NIH would do the same with ME/CFS.

Seriously…

NIH flails about with ME/CFS

Meanwhile, the NIH continues to flail about with ME/CFS. There’s no way our field will be able to keep up with the long-COVID findings without more support.

The NIH continues to flail rather helplessly and, to be honest, rather pitifully about  ME/CFS. A case in point came last week in response to a carefully worded question at the NIH Telebriefing. I asked what the NIH was doing to ensure that the ME/CFS community would quickly benefit from the massive long-COVID effort going forward.

The answer spoke volumes – not so much in what was said but what was unsaid. We learned that the NIH is indeed doing things. It is, for instance, allowing ME/CFS researchers to add long-COVID patients to their studies – and that’s a good thing.

It’s not, though, ensuring that people with ME/CFS will as quickly as possible benefit from long-COVID findings – just the opposite, in fact. It’s pretty well ensuring that people will NOT benefit quickly at all.

For one, those researchers are doing yesterday’s research – they’re not following up on long-COVID findings. For another, the NIH’s small ME/CFS research effort is funding about 15 ME/CFS studies, plus the 3 research centers, for a grand total of about $15 million a year.

Compare that to the massive long COVID RECOVER research program underway. We’re talking 1.15 billion dollars massive, 17,000 participants massive, 100 researchers, 32 major research sites, 4 data repositories – massive. We’re talking probably hundreds of highly sophisticated studies. They should produce results – probably lots of results – and those results will need to be assessed in ME/CFS.

NIH Launches Mammoth Effort to Understand and Treat Long COVID

There’s just no way for our small field to keep up.

Of course, we are going to benefit. The long-COVID findings will slowly trickle down, they will prompt more researchers to study ME/CFS, and knowledgeable doctors will apply new treatment options to their ME/CFS patients. No matter what the NIH does or doesn’t do, we’re on the upward track. We’re in magnitudes better shape than in pre-pandemic times when the NIH had its 20 or 30-year “plan” to build a decent ME/CFS research effort.

That scenario doesn’t even begin, though, to take into account the real possibilities present: of the original long haulers – the really long haulers – getting the help they richly deserve. Morality doesn’t have a place in the NIH stats, but the people who work there are humans and that means morality does apply – and there’s something morally and ethically right about people with ME/CFS benefitting quickly, and something morally wrong about that not happening. You don’t need a science degree to understand that.

Permeating the unsaid in the NIH’s response, though, was the same message we’ve heard again and again: “Read my lips: you’re on your own”. Maybe that will change. For now, the message remains the same.

Let’s make that be a promise they don’t keep for us and for them.

An NIH at Odds with Itself

I say the NIH is suffering. I doubt that anyone with ME/CFS would lose sleep over that idea, but nevertheless, I assert it’s true.

The NIH is suffering because it’s not living up to its ideals as an organization. Every time it kicks ME/CFS or fibromyalgia in the teeth it makes a mockery of its mission statement to provide “leadership and direction to programs designed to improve the health of the Nation“, and its commitmentto exemplify and promote the highest level of scientific integrity, public accountability, and social responsibility in the conduct of science.”

Neither of those, statements after all, came with an asterisk (*except for diseases like chronic fatigue syndrome, fibromyalgia, and the like). Whether the NIH  likes it or not, it has a commitment to help everyone who is ill and that’s about as sacred a commitment as you can get. For whatever reason, it’s allowed something to get in the way of honoring its sacred commitment.

Pointing to all the good the NIH does do doesn’t wipe away that stain. Nor do justifications like “ME/CFS is too complex”, or “it’s a wastebasket disease”, or “we don’t like working with them”, or whatever gets said.

All organizations, of course, are susceptible to drift. As human beings, we excel at that. We all get sidetracked. Getting sidetracked is part of being human condition, but so is wrenching ourselves back to our core commitments and living out of them. The NIH seemed to wrench itself back to its core promise to the nation seven years ago when we had what you could call our George Bush moment.

Our George Bush Moment

President George Bush Sr (7109354619)

George Bush’s “read my lips” moment cost him when he failed to deliver.

George Bush’s promise during the 1988 Republican Convention, “Read my lips: no new taxes“, made the headlines. Republicans thrilled to the line in the sand Bush drew – and Bush paid for it when he didn’t keep his word.

Thirty-two years later on Oct. 29th, 2015 we had our own George Bush moment when NIH Director Francis Collins said: “Give us a chance to prove we’re serious because we are.” Seven years later, Collins’ stirring words have proved to be empty indeed. Only Collins knows if he was sincere at that moment. I chose to believe that he was, but whether through inattention, other priorities, obstruction, or whatever, he was thwarted from keeping his promise to the million or so people with ME/CFS in the U.S.

There’s no doubt that fulfilling that promise wasn’t going to be easy, and we shouldn’t underestimate the difficulties that supporters like NINDS Director Walter Koroshetz or NINDS liaison Vicky Whittemore or NAIAD liaison Joe Breen face. My guess is that each of them would love to see ME/CFS receive many times the level of support that it does. In their own way, they have moved mountains.

It’s still remarkable, for me, to see the director of a $2.8 billion Institute – Walter Koroshetz – consistently show up at our little ME/CFS telebriefings (and get the same tough questions again and again). It was remarkable that Koroshetz has been unusually honest in acknowledging the need for many more ME/CFS research facilities. It was good to see him and Vicky Whittemore create the year-long effort to get a strategic plan for ME/CFS on track. I believe Koroshetz cares.

Did a Pivotal Moment For ME/CFS Just Happen?

Similarly, Francis Collins – the former director of the $41 billion NIH – apparently came up with, or made real, the idea of the intramural NIH study, helped get the research center’s funding going, and actually devoted one of his monthly Director’s blogs to the subject of ME/CFS.

I don’t think we ever had an Institute director, let alone an NIH director even publicly mentioned ME/CFS. Prior to the Collins/Koroshetz effort, we were stuck in the little Office of Research on Women’s Health, getting $6 million in funding a year and declining.

Yet even with their public support, here we are. Even with long COVID and ME/CFS in the news constantly, and the pandemic producing an ME/CFS-like condition in millions of people in the U.S., our standing may have actually declined in the NIH. We’ve been denied entry into the RECOVER Initiative and the NIH apparently has no plans to ensure that our community quickly benefits from it. Even with these immense opportunities present, and with the former Director of the NIH and the current Director of NINDS giving us their public support, we’ve basically been locked out again!

Will the Real NIH Stand Up?

The confusing path NIH continues on regarding ME/CFS – promoting it in one venue / shutting down opportunities in another – reminds us that the NIH is actually a bunch of people working together, many of whom have different ideas and priorities.

Changes in the NIH’s RECOVER website indicated that someone clearly didn’t want ME/CFS associated with long COVID when a perfectly innocuous statement about ME/CFS research contributing to long-COVID research (and in the accompanying link, as I remember, contributing from long-COVID research). Note that the statement didn’t commit the NIH to spend money on ME/CFS – it simply stated that it was possible the two diseases might benefit from each other. That was too much for somebody. It was removed.

The Wayback program indicated that in November of last year, the RECOVER website said this:

 

By Jan. 2022 it said this

NIH RECOVER ME/CFS – Long COVID Webinar on the 12th

Recover? But for whom? That’s the big question. Please register for this event.

That’s not the end of the story, though. Someone, or some group of people, got the ME/CFS connection to long COVID included on a list of the RECOVER webinars! That webinar – featuring David Systrom, Nancy Klimas, and Benjamin Natelson – occurs tomorrow from 12:00 PM – 1:30 PM EDT.

This is a late notice, for sure, but the NIH mailed out the wrong link and didn’t provide a link to its website. Until their email today, there was no way to register. Now there is. Let’s show up and let the RECOVER Initiative know that we count.

Register Here 

Keeping Possibility Alive

Possibilities

Immense possibilities exist – if we keep focused on them.

Despite the NIH’s current intransigence regarding ME/CFS, immense possibilities loom and they are what we must focus on. Unprecedented amounts of money are going into studying “ME/CFS” (or at least a coronavirus-induced branch of it).

Our goal now has to be to keep those possibilities alive, and when confronted with difficulties – not give into the lure of resignation and disappointment.

There are numerous ways the ME/CFS community could rapidly benefit from the NIH’s long-COVID RECOVER initiative. The NIH could spend a little of the $2 billion or more increase in funding it’s slated to get this year – and add a cohort of ME/CFS patients to its RECOVER Initiative. That would be easy, cheap, and effective.

It could also create a long-COVID-ME/CFS grant opportunity that supports research into both diseases. Similarly, it could create a post-infectious disease initiative that seeks to integrate long-COVID research with other post-infectious diseases like ME/CFS, post-Lyme Treatment Disease, post- Giardia, post- EBV, etc. It could increase the number of ME/CFS Research Centers and integrate them with the long-COVID research centers.

Surely many other possibilities are present. If we act out of the possibilities present, instead of the difficulties, we can move mountains.

Our best way to do that right now is to support Advocacy Month in the U.S.. If you live in the U.S. and do one advocacy action a year, make it during Advocacy Month – where we go for the gusto – and affect change where it can make the most difference -at the federal level. Two years ago, ME/CFS advocates contributed to the $1.15 billion in funding provided for long COVID. Everyone who participated in that gets to have a piece of that. More opportunities loom this year – don’t miss them.

 Sign Up Here to Participate in Advocacy Month 

 

 

GET FREE ME/CFS AND FIBROMYALGIA INFO

Like the blog you're reading? Don't miss another one.

Get the most in-depth information available on the latest ME/CFS and FM treatment and research findings by registering for Health Rising's free  ME/CFS and Fibromyalgia blog here.

Pin It on Pinterest

Shares
Share This